Chen W, Reese V A, Cheever M A
Department of Medicine, University of Washington, Seattle 98195.
J Immunol. 1990 May 15;144(10):3659-66.
The aim of the current study was to determine whether cultured tumor Ag-specific T cells could be induced to grow and maintained functional in large numbers in vivo by intermittent restimulation in vivo with specific Ag plus IL-2. T cells derived from spleens of B6 mice (Thy-1.2) immune to FBL-3, a Friend virus-induced leukemia, were activated by in vitro stimulation with irradiated FBL-3 and expanded by culture for 14 days with low concentrations of IL-2. The resultant FBL-3-specific T cell lines were adoptively transferred into cyclophosphamide pretreated congenic hosts (B6/Thy-1.1), and restimulated every 14 days by an injection of irradiated FBL-3 plus a 7-day course of IL-2. Donor T cells residing in the host were identified and quantified by use of antibody to the Thy-1.2 allele. The results confirmed that stimulation with FBL-3 on the day of transfer (day 0) plus IL-2 on days 0 to 6 induced rapid growth of donor T cells to approximately an 11-fold increase in total donor T cell number recoverable from host ascites and spleen by day 7. However, prolonging the course of IL-2 administration to 35 days did not maintain the number or the specific cytolytic function of donor T cells. By contrast, intermittent restimulation with specific Ag plus IL-2 induced intermittent regrowth of donor T cells in vivo, maintained the number of donor T cells in vivo at greater than the number input for longer than 1 mo, and allowed detection of substantially augmented donor T cell-mediated specific antitumor function over that period of time.
本研究的目的是确定通过在体内用特异性抗原加白细胞介素-2进行间歇性再刺激,是否能够诱导培养的肿瘤抗原特异性T细胞在体内大量生长并维持其功能。从对Friend病毒诱导的白血病FBL-3免疫的B6小鼠(Thy-1.2)脾脏中获得的T细胞,通过用经辐照的FBL-3进行体外刺激而被激活,并在低浓度白细胞介素-2存在下培养14天进行扩增。将所得的FBL-3特异性T细胞系过继转移到经环磷酰胺预处理的同基因宿主(B6/Thy-1.1)中,并每隔14天通过注射经辐照的FBL-3加为期7天的白细胞介素-2疗程进行再刺激。通过使用针对Thy-1.2等位基因的抗体来鉴定和定量宿主中存在的供体T细胞。结果证实,在转移当天(第0天)用FBL-3刺激并在第0至6天用白细胞介素-2刺激,可诱导供体T细胞快速生长,到第7天时,从宿主腹水和脾脏中可回收的供体T细胞总数增加约11倍。然而,将白细胞介素-2给药疗程延长至35天并不能维持供体T细胞的数量或特异性细胞溶解功能。相比之下,用特异性抗原加白细胞介素-2进行间歇性再刺激可诱导供体T细胞在体内间歇性再生,使体内供体T细胞数量在超过输入数量的水平上维持超过1个月,并在这段时间内检测到供体T细胞介导的特异性抗肿瘤功能大幅增强。